Pages that link to "Q44220837"
Jump to navigation
Jump to search
The following pages link to The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats (Q44220837):
Displaying 27 items.
- Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt/GSK-3β Pathway in Adult Rat Prefrontal Cortex (Q24612550) (← links)
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q28244389) (← links)
- Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? (Q30379983) (← links)
- The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats (Q30473345) (← links)
- Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors (Q30491856) (← links)
- Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs (Q30491998) (← links)
- Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats (Q33936354) (← links)
- Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). (Q34395427) (← links)
- The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. (Q34725251) (← links)
- Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats. (Q34992163) (← links)
- Glutamate as a therapeutic target in psychiatric disorders (Q35847653) (← links)
- Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment (Q36252816) (← links)
- Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions (Q36756365) (← links)
- Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
- The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment (Q37826638) (← links)
- Metabotropic glutamate receptors as therapeutic targets for schizophrenia (Q37881198) (← links)
- Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task (Q38223390) (← links)
- Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants (Q43286008) (← links)
- Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli (Q44642268) (← links)
- Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex (Q44646831) (← links)
- Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists (Q45248983) (← links)
- The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. (Q46506812) (← links)
- Low doses of memantine disrupt memory in adult rats. (Q48586193) (← links)
- Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats (Q51015703) (← links)
- Attention deficit induced by blockade of N-methyl d-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3 (Q83067494) (← links)
- Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission (Q83844776) (← links)
- Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type? (Q91867564) (← links)